GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daehan New Pharm Co Ltd (XKRX:054670) » Definitions » Net Margin %

Daehan New Pharm Co (XKRX:054670) Net Margin % : 10.34% (As of Jun. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Daehan New Pharm Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Daehan New Pharm Co's Net Income for the three months ended in Jun. 2024 was ₩5,599 Mil. Daehan New Pharm Co's Revenue for the three months ended in Jun. 2024 was ₩54,138 Mil. Therefore, Daehan New Pharm Co's net margin for the quarter that ended in Jun. 2024 was 10.34%.

The historical rank and industry rank for Daehan New Pharm Co's Net Margin % or its related term are showing as below:

XKRX:054670' s Net Margin % Range Over the Past 10 Years
Min: -15.73   Med: 4.15   Max: 12.28
Current: 6.19


XKRX:054670's Net Margin % is ranked better than
58.13% of 1008 companies
in the Drug Manufacturers industry
Industry Median: 3.665 vs XKRX:054670: 6.19

Daehan New Pharm Co Net Margin % Historical Data

The historical data trend for Daehan New Pharm Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daehan New Pharm Co Net Margin % Chart

Daehan New Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.36 -6.78 9.42 12.28 6.14

Daehan New Pharm Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.16 10.12 -6.50 10.81 10.34

Competitive Comparison of Daehan New Pharm Co's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Daehan New Pharm Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daehan New Pharm Co's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daehan New Pharm Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Daehan New Pharm Co's Net Margin % falls into.



Daehan New Pharm Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Daehan New Pharm Co's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=12541.894/204222.611
=6.14 %

Daehan New Pharm Co's Net Margin for the quarter that ended in Jun. 2024 is calculated as

Net Margin=Net Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=5599.384/54137.727
=10.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Daehan New Pharm Co  (XKRX:054670) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Daehan New Pharm Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Daehan New Pharm Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Daehan New Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
1062-4 Namhyeon-dong, Gwanak-gu, Seoul, KOR, 137-851
Daehan New Pharm Co Ltd is a South Korea based company operating in the pharmaceutical sector. It is engaged in producing pharmaceutical products, animal health and nutrition, and bio products. The pharmaceutical products are tertan tab, amloc tab, tarocin SR tab, NP star tab and others. The animal health and nutrition products are starvac, pigcoc for calves, ocean doctor, and others. The bio range of the products by the group are CELRENA serum-free, BMPro serum-free, BMPro-V serum-free, ALyS505NK-EX serum-free and others.

Daehan New Pharm Co Headlines

No Headlines